Literature DB >> 16515019

Pneumatic displacement of a dense submacular hemorrhage with or without tissue plasminogen activator.

Po-Min Yang1, His-Kung Kuo, Min-Lun Kao, Yung-Jen Chen, Hsih-Hao Tsai.   

Abstract

BACKGROUND: To evaluate the efficacy of treating a dense submacular hemorrhage with pneumatic displacement with or without tissue plasminogen activator (tPA).
METHODS: Twenty-four patients with a dense submacular hemorrhage were treated with intravitreal expansile gas, with or without an intravitreal injection of tPA, in order to displace the submacular blood. The main outcome measurements include preoperative and postoperative visual acuity, postoperative fluorescein angiography (FAG) results and additional postoperative treatments.
RESULTS: Total or subtotal subfoveal blood displacement was achieved in all 24 eyes. After a mean follow-up of 15.5 months (range 6-50 months), final visual acuity had improved two or more lines in 11 (45.8%) of the 24 eyes, and measured 20/100 or better in 10 (41.7%) of the 11 eyes. Based on the FAG results for 14 cases, nine eyes (64.3%) received additional postoperative laser treatment. Final visual acuity of 20/100 or better was achieved in four (40%) of the 10 eyes, with a choroidal neovascular membrane (CNVM) detected on FAG, and dye leakage not detected in three (75%) of the four eyes.
CONCLUSIONS: Pneumatic displacement, with or without intravitreal injection of tPA, seems useful in displacing dense submacular hemorrhage and facilitating visual improvement, although the visual result is often limited by the progression of the underlying macular disease. In patients with age-related macular degeneration, more treatable CNVM may be detected on postoperative FAG.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16515019

Source DB:  PubMed          Journal:  Chang Gung Med J        ISSN: 2072-0939


  4 in total

1.  Recombinant tissue plasminogen activator, vitrectomy, and gas for recent submacular hemorrhage displacement due to retinal macroaneurysm.

Authors:  Elsbeth J T van Zeeburg; Matteo G Cereda; Jan C van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-04       Impact factor: 3.117

2.  Subretinal recombinant tissue plasminogen activator and pneumatic displacement for the management of subretinal hemorrhage occurring after anti-VEGF injections for wet AMD.

Authors:  Daniele Tognetto; Eirini Skiadaresi; Paolo Cecchini; Giuseppe Ravalico
Journal:  Clin Ophthalmol       Date:  2011-04-13

3.  Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm.

Authors:  Yasmin Ali Said; Evelien Dewilde; Peter Stalmans
Journal:  J Ophthalmol       Date:  2021-12-30       Impact factor: 1.909

4.  Successful displacement of a traumatic submacular hemorrhage in a 13-year-old boy treated by vitrectomy, subretinal injection of tissue plasminogen activator and intravitreal air tamponade: a case report.

Authors:  Shinichiro Doi; Shuhei Kimura; Yuki Morizane; Yusuke Shiode; Mio Hosokawa; Masayuki Hirano; Mika Hosogi; Atsushi Fujiwara; Kazuhisa Miyamoto; Fumio Shiraga
Journal:  BMC Ophthalmol       Date:  2015-08-07       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.